XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: A meta-analysis

By Yan Yulan   Liang Hongjie   Light Morning   Li Taijie   Deng Yan   Li Meng   Li Shan   Qin Xue  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 1907-1915

Springer Publishing Company

Access to resources Recommend Favorite

Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer

By Pabalan Noel  

Breast Cancer Research and Treatment, Vol. 124, Iss. 2, 2010-11 ,pp. : 531-541

Springer Publishing Company

Access to resources Recommend Favorite

XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects

By Qiu Li-Xin  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 229-235

Springer Publishing Company

Access to resources Recommend Favorite

Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case–control studies

By Ding Da-Peng   He Xiao-Feng   Zhang Ying  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 203-209

Springer Publishing Company

Access to resources Recommend Favorite

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies

By Liang Hongjie   Yan Yulan   Li Taijie   Li Ruolin   Li Meng   Li Shan   Qin Xue  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1695-1701

Springer Publishing Company

Access to resources Recommend Favorite